NEO-X-PRIME Trademark
Trademark Overview
On Thursday, March 14, 2024, a trademark application was filed for NEO-X-PRIME with the United States Patent and Trademark Office. The USPTO has given the NEO-X-PRIME trademark a serial number of 79396585. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 21, 2025. This trademark is owned by Alligator Bioscience AB. The NEO-X-PRIME trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Antibodies and libraries of antibodies for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for immuno-oncological applications; immuno-oncology preparations for medical and pharmaceutical purposes; antibodies; none of the aforesaid goods being for use in newborn screening and invitro.
Antibodies [for scientific and immuno-oncological use]; libraries and collections of antibodies; antibody formats; bispecific antibody formats, therapeutic antibodies; bispecific antibody formats for immuno-oncological applications; bispecific compounds; none of the aforesaid goods being for use in newborn screening and invitro.
Bio-technology and scientific research services relating to antibodies, antibody formats, bispecific antibody formats, therapeutic antibodies, and immune-oncology preparations; biochemical research and development in the field of antibodies, protein and enzyme; scientific laboratory services relating to antibodies, protein and enzyme; research, production and development services relating to antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds; research, development and production of immuno-oncology antibody preparations and pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid services; none of the aforesaid goods being for use in newborn screening and invitro.
General Information
Serial Number | 79396585 |
Word Mark | NEO-X-PRIME |
Filing Date | Thursday, March 14, 2024 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, April 21, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Antibodies and libraries of antibodies for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for immuno-oncological applications; immuno-oncology preparations for medical and pharmaceutical purposes; antibodies; none of the aforesaid goods being for use in newborn screening and invitro. |
Goods and Services | Antibodies [for scientific and immuno-oncological use]; libraries and collections of antibodies; antibody formats; bispecific antibody formats, therapeutic antibodies; bispecific antibody formats for immuno-oncological applications; bispecific compounds; none of the aforesaid goods being for use in newborn screening and invitro. |
Goods and Services | Bio-technology and scientific research services relating to antibodies, antibody formats, bispecific antibody formats, therapeutic antibodies, and immune-oncology preparations; biochemical research and development in the field of antibodies, protein and enzyme; scientific laboratory services relating to antibodies, protein and enzyme; research, production and development services relating to antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds; research, development and production of immuno-oncology antibody preparations and pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid services; none of the aforesaid goods being for use in newborn screening and invitro. |
Classification Information
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 30, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 30, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 30, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Alligator Bioscience AB |
Party Type | 10 - Original Applicant |
Legal Entity Type | 98 - Unknown |
Address | SE |
Trademark Events
Event Date | Event Description |
Thursday, May 30, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Saturday, June 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, September 24, 2024 | ASSIGNED TO EXAMINER |
Thursday, September 26, 2024 | NON-FINAL ACTION WRITTEN |
Saturday, June 1, 2024 | APPLICATION FILING RECEIPT MAILED |
Friday, September 27, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, October 2, 2024 | REFUSAL PROCESSED BY MPU |
Wednesday, October 2, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Saturday, October 19, 2024 | REFUSAL PROCESSED BY IB |
Monday, April 21, 2025 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, April 21, 2025 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |